Perrigo (PRGO) Common Equity (2012 - 2026)
Perrigo (PRGO) reported Common Equity of $2.5 billion for Q1 2026, down 42.74% year-over-year from $4.4 billion in Q1 2025, and down 14.88% quarter-over-quarter from $2.9 billion in Q4 2025.
Perrigo (PRGO) Common Equity (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Common Equity data on file, last reported at $2.5 billion in Q1 2026.
- Common Equity for Q1 2026 came in at $2.5 billion, down 42.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 billion (down 42.74% YoY), and the FY2025 annual result was $2.9 billion, down 32.04% from the prior year.
- Common Equity fell to $2.5 billion in Q1 2026 per PRGO's latest filing, from $2.9 billion in the prior quarter.
- Over five years, Common Equity peaked at $5.1 billion in Q2 2022 and troughed at $2.5 billion in Q1 2026.
- A 5-year average of $4.4 billion and a median of $4.6 billion in 2022 frame the typical range for Common Equity.
- The sharpest annual moves came in 2023 and 2026: Common Equity gained 2.94% in 2023, then slumped 42.74% in 2026.
- A 5-year view of Common Equity shows it stood at $4.8 billion in 2022, then dropped by 1.53% to $4.8 billion in 2023, then declined by 9.41% to $4.3 billion in 2024, then sank by 32.04% to $2.9 billion in 2025, then declined by 14.88% to $2.5 billion in 2026.
- Business Quant data shows PRGO's Common Equity at $2.5 billion in Q1 2026, $2.9 billion in Q4 2025, and $4.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | 2.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2.50 Bn |
| Dec 31, 2025 | 2.94 Bn |
| Sep 27, 2025 | 4.45 Bn |
| Jun 28, 2025 | 4.47 Bn |
| Mar 29, 2025 | 4.36 Bn |
| Dec 31, 2024 | 4.32 Bn |
| Sep 28, 2024 | 4.57 Bn |
| Jun 29, 2024 | 4.55 Bn |
| Mar 30, 2024 | 4.69 Bn |
| Dec 31, 2023 | 4.77 Bn |
| Sep 30, 2023 | 4.74 Bn |
| Jul 1, 2023 | 4.85 Bn |
| Apr 1, 2023 | 4.83 Bn |
| Dec 31, 2022 | 4.84 Bn |
| Oct 1, 2022 | 4.60 Bn |
| Jul 2, 2022 | 4.85 Bn |
| Apr 2, 2022 | 5.10 Bn |
| Dec 31, 2021 | 5.15 Bn |
| Oct 2, 2021 | 5.18 Bn |
| Jul 3, 2021 | 5.51 Bn |